[HTML][HTML] Involvement of the liver in COVID-19: A systematic review

JC Kariyawasam, U Jayarajah… - The American journal …, 2022 - ncbi.nlm.nih.gov
COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …

COVID-19 in Brazil: a three-year update

JP Martins, BA Siqueira, NMS Sansone… - … and Infectious Disease, 2023 - Elsevier
Three years into the coronavirus disease (COVID)-19 pandemic and the world is still
struggling with the aftermath of this global health crisis. In Brazil, we are witnessing serious …

Timing of elective surgery and risk assessment after SARS‐CoV‐2 infection: an update: a multidisciplinary consensus statement on behalf of the Association of …

K El‐Boghdadly, TM Cook, T Goodacre, J Kua… - …, 2022 - Wiley Online Library
The impact of vaccination and new SARS‐CoV‐2 variants on peri‐operative outcomes is
unclear. We aimed to update previously published consensus recommendations on timing …

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA. 1 variant predominance …

K Adams, JJ Riddles, EAK Rowley… - The Lancet Regional …, 2023 - thelancet.com
Background Understanding the usefulness of additional COVID-19 vaccine doses—
particularly given varying disease incidence—is needed to support public health policy. We …

Association between COVID-19 diagnosis and coronary artery thrombosis: a narrative review

F Nappi, O Giacinto, O Ellouze, A Nenna… - Biomedicines, 2022 - mdpi.com
Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

Evaluating possible mechanisms linking obesity to COVID-19: a narrative review

M Vasheghani, Z Hessami, M Rekabi, A Abedini… - Obesity surgery, 2022 - Springer
Currently, pneumonia caused by the coronavirus disease 2019 (COVID-19) is a pandemic.
To date, there is no specific antiviral treatment for the disease, and universal access to the …

Severity of prior coronavirus disease 2019 is associated with postoperative outcomes after major inpatient surgery

NB Verhagen, G SenthilKumar, T Jaraczewski… - Annals of …, 2023 - journals.lww.com
Objective: To determine how the severity of prior history (Hx) of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection influences postoperative outcomes after …

Epidemiological profile of hospitalized patients with cystic fibrosis in Brazil due to severe acute respiratory infection during the COVID-19 pandemic and a systematic …

LS Marques, MN Boschiero, NMS Sansone… - Healthcare, 2023 - mdpi.com
Since the onset of the coronavirus disease, COVID-19 pandemic, concern arose for those
who might be at higher risk of a worse COVID-19 prognosis, such as those with cystic …

SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19

L Yu, MK Abd Ghani, A Aghemo, D Barh… - Current Medicinal …, 2023 - ingentaconnect.com
The COVID-19 pandemic, caused by the coronavirus, SARS-CoV-2, has claimed millions of
lives worldwide in the past two years. Fatalities among the elderly with underlying …

Thromboembolic disease and cardiac thrombotic complication in COVID-19: a systematic review

F Nappi, P Nappi, I Gambardella, SS Avtaar Singh - Metabolites, 2022 - mdpi.com
The coronavirus 2019 pandemic has affected many healthcare systems worldwide. While
acute respiratory distress syndrome (ARDS) has been well-documented in COVID-19, there …